An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations-Reference-Cited by-同舟云学术

An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations

Published:2003-01 Issue:1 Volume:25 Page:235-246
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Weidmann Eric,Unger Jeffrey,Blair Stephen,Friesen Christopher,Hart Carolyn,Cady Roger

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference14 articles.

1. Stepping up to stratified care for migraine headaches: MCOs that embrace severity and control needs can cut costs and improve outcomes over time;Mulligan;Manag Health Care,1998

2. Stratified care vs step care strategies for migraine. The Disability in Strategies of Care (DISC) study: A randomized trial;Lipton;JAMA,2000

3. Current treatment strategies for migraine disorder;Ramadan;Am J Manag Care,1998

4. Migraine: Diagnosis and treatment,1998

5. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain;Headache Classification Committee of the International Headache Society;Cephalalgia,1988

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient Preferences and Values in Decision Making for Migraines: A Systematic Literature Review;Pain Research and Management;2021-09-17

2. Determining patient treatment preferences for management of acute pain episodes in irritable bowel syndrome;Neurogastroenterology & Motility;2021-04-02

3. DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhancer, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Study Assessing Functional Disability and Subject Satisfaction with Treatment;CNS Drugs;2019-03-15

4. A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine;The Journal of Headache and Pain;2017-03-01

5. A Systematic Review of Patients’ Perspectives on the Subcutaneous Route of Medication Administration;The Patient - Patient-Centered Outcomes Research;2016-01-20